Movatterモバイル変換


[0]ホーム

URL:


CN105943186A - Establishment method for chronic high intraocular pressure animal model - Google Patents

Establishment method for chronic high intraocular pressure animal model
Download PDF

Info

Publication number
CN105943186A
CN105943186ACN201610249471.5ACN201610249471ACN105943186ACN 105943186 ACN105943186 ACN 105943186ACN 201610249471 ACN201610249471 ACN 201610249471ACN 105943186 ACN105943186 ACN 105943186A
Authority
CN
China
Prior art keywords
intraocular pressure
animal model
schlemm
chronic
building
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610249471.5A
Other languages
Chinese (zh)
Inventor
梁远波
胡城
廖娜
徐晶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wenzhou Yan Shiguang Development Co Ltd
Original Assignee
Wenzhou Yan Shiguang Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wenzhou Yan Shiguang Development Co LtdfiledCriticalWenzhou Yan Shiguang Development Co Ltd
Priority to CN201610249471.5ApriorityCriticalpatent/CN105943186A/en
Publication of CN105943186ApublicationCriticalpatent/CN105943186A/en
Priority to PCT/CN2017/078965prioritypatent/WO2017181835A1/en
Priority to JP2018532502Aprioritypatent/JP6505325B2/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

Provided is an establishment method for a chronic high intraocular pressure animal model. Through placing materials to block an outflow pathway of aqueous humor by operation, a glaucoma animal model which is increased in intraocular pressure and damaged in optic nerve is made. Increased intraocular pressure is maintained stable, and the intraocular pressure is easy to obtain and operate. The obtained model is advantaged in stable intraocular pressure increasing, low fluctuation, long high intraocular pressure duration time, and controllable target intraocular pressure. The intraocular pressure of the chronic high intraocular pressure animal model made by the method can be regulated according to different Schlemm blocking ranges. According to Schlemm pipe diameters of different animal kinds, fiber conduits in different specifications and dimensions can be selected, so as to complete blocking of the Schlemm pipe, and generate chronic high intraocular pressure models of various kinds of animals. Preferably establishing modeling animals and modeling methods fit with clinic in chronic high intraocular pressure glaucoma mechanism research provides foundation for chronic glaucoma optic nerve injury mechanism.

Description

A kind of method for building up of chronic intraocular hypertension animal model
Technical field
The present invention relates to medical animal model field, be specifically related to the method for building up of a kind of chronic intraocular hypertension animal model.
Background technology
Glaucoma is a kind of irreversibility optic nerve degeneration, for whole world second diseases causing blindness.The pathogenesis of its complexity is the most still not very clear, although Bulbi hypertonia is not the single factor that glaucoma regards infringement, but Bulbi hypertonia is one of factor the most dangerous in Deterioration of Optic Nerve in Glaucoma generation and development mechanism.In GLAUCOMA RESEARCH field, animal model has become important research tool.Glaucoma animal model has important effect for the damage mechanisms and remedy measures being better understood from glaucomatous optic neuropathy.Bulbi hypertonia is the topmost risk factor of Deterioration of Optic Nerve in Glaucoma, so the animal model of most of GLAUCOMA RESEARCH remains induced animal Bulbi hypertonia, and then studies the aspects such as the physiology of glaucoma, pathology, pharmacology.Preferably experimental animal model requires: its construction method is simple, with low cost, it is easy to raise and control, and the intraocular pressure of rising remains stable, and the distinctive pathological change of retina optic nerve occurs.
The animal being currently used for making glaucoma model is low mammal such as grade, mainly has rabbit, Mus, monkey.Although Mus is prone to transgenic technology transformation and breeding, and the structure of rathole is similar with human eye at a lot of aspects, and such as girder, Schlemm pipe, corpus ciliare, retinal vessel etc., but rathole is relatively small, is unfavorable for being operated.The Ocular hypertensive model of the monkey of induced with laser is the optimal Bulbi hypertonia animal model generally acknowledged at present, but because involving great expense, operates more complicated, and domestic application is few.Although lagophthalmos has Morphological Differences with the chamber-angle structure of human eye, but ah outflow passage is identical, has continuous print endotheliocyte liner.And rabbit price is inexpensive, personality is docile, be easily obtained and operate, therefore rabbit is most commonly used for making the laboratory animal of glaucoma model.
It is divided into according to Bulbi hypertonia Forming Mechanism and medicine site of action and acts on angle of anterior chamber (and girder) type, such as injected into anterior chambers hyaluronic acid, methylcellulose, hemocyte, Carbomer liquid, back room injection 5. Chymotrypsin, laser photocoagulation trabecular reticulum, the method such as eyes external corticosteroid hormone;Act on the most conventional scleral surface intravenous injection hypertonic saline method (Morre-Morrison model) of sclera aqueous humor drains intravenous type, burn episcleral aqueous humor drainage vein method (Shareef-Sharma model) and modification method;Additionally, also have the spontaneous mouse of some special germlines and transgenic technology to build glaucoma model, such as the mouse inbred lines of DBA/2J and AKXD-28/Ty, utilize the natural glaucoma model etc. that gene targeting builds.The most various models pathologic in terms of retinal ganglial cells (RGCs), optic nerve, retinal function is changed and be evaluated, assess the Positive and Negative Aspects of various model, preferably build, in chronic intraocular hypertension glaucoma Mechanism Study, the modeling animal agreed with mutually with clinic and modeling method provides foundation, the more mechanism of in-depth study chronic intraocular hypertension glaucoma, provides new thinking for its treatment.
Although the method making Bulbi hypertonia animal model has a lot, but current glaucoma animal model great majority are all acute high IOP models, although intraocular pressure raises, but its Bulbi hypertonia is held time short, and it is big to fluctuate, it is difficult to simulate the characteristic optic nerve lesion of glaucoma.
Summary of the invention
In order to overcome the defect of prior art, the invention provides the method for building up of a kind of chronic intraocular hypertension animal model.
The technical solution that the present invention uses is: the method for building up of a kind of chronic intraocular hypertension animal model, comprise the following steps: animal pattern bondage is lain on the back in operating-table by (1), art eye sterile drape, put eye speculum, rinse conjunctival sac, under art eye conjunctiva after the anesthesia of local profit, do superior rectus traction sutures and fix;
(2) timepiece dial telegoniometer is pressed, in 11 positions to 1 position edge ring bulbar conjunctiva incision, centered by 12 positions, place makees the shallow-layer scleral flap of 1/3 scleral thickness of size 4*4mm with limbus of corneae as substrate, size 3*3mm is done again below shallow-layer scleral flap, the Deep Layer of Sclera lobe of thickness 2/3 scleral thickness, and peel off to cornea direction, find Schlemm to manage and cut Schlemm pipe outer wall;
(3) in Schlemm pipe two ends, polymer hyaluronic acid is injected, fiber duct conduit is passed through opening, in 9 or 3 o ' clock orientation limbus of corneae at 1.0 mm, flat iris direction row paracentesis of anterior chamber, light pressure puncture orifice trailing edge, release water and reduce intraocular pressure, anterior chamber is reduced pressure and fiber duct is inserted after puncturing the broken ends of fractured bone of Schlemm pipe, 360 degree or 270 degree or 180 degree or 90 degree are detoured along Schlemm pipe, cut off conduit, it is placed in Schlemm blocking Schlemm pipe, stop ah outflow, sew up scleral flap, , paracentesis of anterior chamber mouth injection balance saline solution, sew up conjunctival flap, give anti-inflammatory drug, finally set up the animal model that intraocular pressure raises.
Described step (1) use dilution iodophor solution rinse conjunctival sac.
Described step (1) use the lignocaine of 0.4ml 2% carry out profit anesthesia in local under art eye conjunctiva.
Described step (1) use 30G syringe needle inject polymer hyaluronic acid in Schlemm pipe two ends.
In described step (3), fiber duct includes a cylindrical solid conduit, and described tube at one end is spherical structure.
The long 10cm of described fiber duct, diameter 200 μm, the spherical diameter of described tube at one end is 250 μm.
Described fiber duct uses polypropylene material to make.
The invention has the beneficial effects as follows: the invention provides the method for building up of a kind of chronic intraocular hypertension animal model, place material by operation and block its aqueous humor flow pass, intraocular pressure is caused to raise the chronic glaucoma animal model of optic nerve lesion, the chronic intraocular hypertension animal model produced by this method, its intraocular pressure can regulate and control according to the scope difference of blocking Schlemm.And the fiber duct of different specification size can be selected according to different animals kind Schlemm caliber, complete Schlemm blockage, thus produce the ocular hypertension model of many animals type.In chronic intraocular hypertension glaucoma Mechanism Study, preferably build the modeling animal agreed with mutually with clinic and modeling method, provide basis for carrying out chronic glaucoma optic nerve injury mechanism.
Accompanying drawing explanation
Fig. 1 is fiber duct structural representation of the present invention.
Detailed description of the invention
In conjunction with Fig. 1, the present invention is further described: operating procedure: operation needs a long 10cm diameter 200 μm solid fibers conduit being made by polypropylene material, the a diameter of 250 μm local bulkiness of conduit head end spherical, damages Schlemm tube wall tissue when preventing from intubating.
Animal pattern extremity bondage is lain on the back in operating-table, art eye routine disinfection drape, put eye speculum, dilution iodophor solution rinses conjunctival sac, take after locally moistening anesthesia under 0.4ml 2% lignocaine Rhizoma Atractylodis Macrocephalae eye conjunctiva, do superior rectus traction sutures to fix, by timepiece dial telegoniometer, in 11 positions to 1 position edge ring bulbar conjunctiva incision, centered by 12 positions, place makees the shallow-layer scleral flap of 1/3 scleral thickness of the size about 4*4mm with limbus of corneae as substrate, a size about 3*3mm, the Deep Layer of Sclera lobe of thickness about 2/3 scleral thickness is done again below shallow-layer scleral flap.And peel off to cornea direction, find Schlemm to manage and cut Schlemm pipe outer wall, in Schlemm pipe two ends, injecting polymer hyaluronic acid (Healon GV) with 30G syringe needle, enable the duct to easily by opening.In 9 or 3 o ' clock orientation limbus of corneae at 1.0 mm, flat iris direction row paracentesis of anterior chamber, light pressure puncture orifice trailing edge, releases appropriate aqueous humor and reduces intraocular pressure, and anterior chamber is reduced pressure and microtubular is inserted after puncturing the broken ends of fractured bone of Schlemm pipe, difference according to required target intraocular pressure, detour 360 degree or 270 degree or 180 degree or 90 degree along Schlemm pipe respectively, cut off conduit, be placed in Schlemm blocking Schlemm pipe, stop ah outflow, cause the model that its intraocular pressure raises.Finally with 10-0 polypropylene line tight suture scleral flap 4-6 pin, paracentesis of anterior chamber mouth injection balance saline solution is observed, and sews up with the non-leakage watertight that is considered as, then with 10-0 polypropylene suturing with thread management conjunctival flap 2 pin.The postoperative anti-inflammatory drug that gives, monitors intraocular pressure, prosthomere response situation.
The present invention places material by operation and blocks its aqueous humor flow pass, intraocular pressure is caused to raise the glaucoma animal model of optic nerve lesion, the chronic intraocular hypertension animal model produced by this method, its intraocular pressure can regulate and control according to the scope difference of blocking Schlemm.And the fiber duct of different specification size can be selected according to different animals kind Schlemm caliber, complete Schlemm blockage, thus produce the ocular hypertension model of many animals type..The fiber duct specification that lagophthalmos, the animal model of monkey eye use can use long 10cm diameter 200 μm, and conduit head end spherical diameter is 250 μm, the optional conduit specification matched with its Schlemm caliber of other animals.In chronic intraocular hypertension glaucoma Mechanism Study, preferably build the modeling animal agreed with mutually with clinic and modeling method, provide basis for carrying out chronic glaucoma optic nerve injury mechanism.
The above is only the preferred embodiment of the present invention, and protection scope of the present invention is not limited merely to above-described embodiment, and all technical schemes belonged under thinking of the present invention belong to protection scope of the present invention.It should be pointed out that, for those skilled in the art, some improvements and modifications without departing from the principles of the present invention, these improvements and modifications also should be regarded as protection scope of the present invention.

Claims (7)

(3) in Schlemm pipe two ends, polymer hyaluronic acid is injected, fiber duct conduit is passed through opening, in 9 or 3 o ' clock orientation limbus of corneae at 1.0 mm, flat iris direction row paracentesis of anterior chamber, light pressure puncture orifice trailing edge, release water and reduce intraocular pressure, anterior chamber is reduced pressure and fiber duct is inserted after puncturing the broken ends of fractured bone of Schlemm pipe, 360 degree or 270 degree or 180 degree or 90 degree are detoured along Schlemm pipe, cut off conduit, it is placed in Schlemm blocking Schlemm pipe, stop ah outflow, sew up scleral flap, , paracentesis of anterior chamber mouth injection balance saline solution, sew up conjunctival flap, give anti-inflammatory drug, finally set up the animal model that intraocular pressure raises.
CN201610249471.5A2016-04-212016-04-21Establishment method for chronic high intraocular pressure animal modelPendingCN105943186A (en)

Priority Applications (3)

Application NumberPriority DateFiling DateTitle
CN201610249471.5ACN105943186A (en)2016-04-212016-04-21Establishment method for chronic high intraocular pressure animal model
PCT/CN2017/078965WO2017181835A1 (en)2016-04-212017-03-31Method for establishing chronic ocular hypertension animal model
JP2018532502AJP6505325B2 (en)2016-04-212017-03-31 Method of producing chronic high intraocular pressure non-human animal model

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201610249471.5ACN105943186A (en)2016-04-212016-04-21Establishment method for chronic high intraocular pressure animal model

Publications (1)

Publication NumberPublication Date
CN105943186Atrue CN105943186A (en)2016-09-21

Family

ID=56917874

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201610249471.5APendingCN105943186A (en)2016-04-212016-04-21Establishment method for chronic high intraocular pressure animal model

Country Status (3)

CountryLink
JP (1)JP6505325B2 (en)
CN (1)CN105943186A (en)
WO (1)WO2017181835A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2017181835A1 (en)*2016-04-212017-10-26温州眼视光发展有限公司Method for establishing chronic ocular hypertension animal model
CN107981969A (en)*2017-12-292018-05-04温州医科大学附属眼视光医院Drainage substitutes biomimetic scaffolds in a kind of glaucoma
CN109481071A (en)*2019-01-162019-03-19沈阳眼产业技术研究院有限公司A kind of method for building up of chronic intraocular hypertension animal model
CN109907857A (en)*2019-02-282019-06-21中国人民解放军第四军医大学 A device for injecting polyester fiber microspheres in front of mouse eyeball
CN111053626A (en)*2019-12-262020-04-24中国人民解放军总医院 A modeling method and animal model and its application
CN113133431A (en)*2021-02-252021-07-20中南大学Establishment method, model and application of chronic ocular hypertension combined long-axis animal model
CN113273546A (en)*2021-02-252021-08-20中南大学Application of lauromacrogol in preparation of chronic ocular hypertension animal model and animal model

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN111110441A (en)*2020-01-082020-05-08孙河 An experimental rat episcleral vein injection device and method

Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20060088909A1 (en)*2002-05-172006-04-27Compans Richard WVirus-like particles, methods of preparation, and immunogenic compositions
CN102665619A (en)*2009-10-232012-09-12孕体股份有限公司Contraceptive devices
CN202637223U (en)*2012-04-242013-01-02东华大学Blocking type birth control device free of damaging fallopian tube organization
CN203355084U (en)*2013-07-102013-12-25高广林Nasobiliary drainage tube
CN103932841A (en)*2011-06-162014-07-23王宁利Schlemm canal expandable stent and combination bodies thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5360399A (en)*1992-01-101994-11-01Robert StegmannMethod and apparatus for maintaining the normal intraocular pressure
JP2002112664A (en)*2000-10-042002-04-16Koken Co LtdMethod for making model animal of glaucoma
JP2003149236A (en)*2001-08-302003-05-21Santen Pharmaceut Co LtdScreening method for glaucoma remedy
US8366653B2 (en)*2007-03-132013-02-05University Of RochesterIntraocular pressure regulating device
US8951221B2 (en)*2009-08-202015-02-10Grieshaber Ophthalmic Research FoundationMethod and device for the treatment of glaucoma
WO2011046949A2 (en)*2009-10-122011-04-21The Regents Of The University Of Colorado, A Body CorporateImplants for reducing intraocular pressure
NL2004047C2 (en)*2010-01-042011-07-05D O R C Dutch Ophthalmic Res Ct International B VAn ophthalmic surgical device and a method of performing ophthalmic surgery.
US20120022424A1 (en)*2010-05-272012-01-26Iscience Interventional CorporationDevice for placing circumferential implant in schlemm's canal
CN105943186A (en)*2016-04-212016-09-21温州眼视光发展有限公司Establishment method for chronic high intraocular pressure animal model

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20060088909A1 (en)*2002-05-172006-04-27Compans Richard WVirus-like particles, methods of preparation, and immunogenic compositions
CN102665619A (en)*2009-10-232012-09-12孕体股份有限公司Contraceptive devices
CN103932841A (en)*2011-06-162014-07-23王宁利Schlemm canal expandable stent and combination bodies thereof
CN202637223U (en)*2012-04-242013-01-02东华大学Blocking type birth control device free of damaging fallopian tube organization
CN203355084U (en)*2013-07-102013-12-25高广林Nasobiliary drainage tube

Cited By (10)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2017181835A1 (en)*2016-04-212017-10-26温州眼视光发展有限公司Method for establishing chronic ocular hypertension animal model
CN107981969A (en)*2017-12-292018-05-04温州医科大学附属眼视光医院Drainage substitutes biomimetic scaffolds in a kind of glaucoma
CN107981969B (en)*2017-12-292023-07-14苏州朗目医疗科技有限公司Replacement bionic bracket for glaucoma internal drainage
CN109481071A (en)*2019-01-162019-03-19沈阳眼产业技术研究院有限公司A kind of method for building up of chronic intraocular hypertension animal model
CN109907857A (en)*2019-02-282019-06-21中国人民解放军第四军医大学 A device for injecting polyester fiber microspheres in front of mouse eyeball
CN109907857B (en)*2019-02-282023-10-31中国人民解放军第四军医大学 A device for injecting polyester fiber microspheres into the front of mouse eyeballs
CN111053626A (en)*2019-12-262020-04-24中国人民解放军总医院 A modeling method and animal model and its application
CN111053626B (en)*2019-12-262021-08-20中国人民解放军总医院 A kind of modeling method and animal model and its application
CN113133431A (en)*2021-02-252021-07-20中南大学Establishment method, model and application of chronic ocular hypertension combined long-axis animal model
CN113273546A (en)*2021-02-252021-08-20中南大学Application of lauromacrogol in preparation of chronic ocular hypertension animal model and animal model

Also Published As

Publication numberPublication date
JP2018527147A (en)2018-09-20
WO2017181835A1 (en)2017-10-26
JP6505325B2 (en)2019-04-24

Similar Documents

PublicationPublication DateTitle
CN105943186A (en)Establishment method for chronic high intraocular pressure animal model
Francis et al.Novel glaucoma procedures: a report by the American Academy of Ophthalmology
Francis et al.Endoscopic ophthalmic surgery of the anterior segment
Richter et al.Minimally invasive glaucoma surgery: current status and future prospects
Kaplowitz et al.Techniques and outcomes of minimally invasive trabecular ablation and bypass surgery
US11707383B2 (en)Inner drainage biomimetic stent for glaucoma and use thereof
Chang et al.Comparison of clear corneal phacoemulsification combined with 25-gauge transconjunctival sutureless vitrectomy and standard 20-gauge vitrectomy for patients with cataract and vitreoretinal diseases
Gelatt et al.Surgical procedures of the lens and cataract
Gurnani et al.Manual small incision cataract surgery
CN113273546A (en)Application of lauromacrogol in preparation of chronic ocular hypertension animal model and animal model
Hwang et al.Combined phacoemulsification, foldable intraocular lens implantation, and 25-gauge transconjunctival sutureless vitrectomy
Gurnani et al.Evolution of manual small-incision cataract surgery from 8 mm to 2 mm-A comprehensive review
Hu et al.Glaucoma animal models in rabbits: State of the art and perspectives—A review
US10076443B2 (en)Penetrating canaloplasty for treating angle-closure glaucoma
Larsen et al.Managing coexistent cataract and glaucoma with iStent
Kam et al.New endoscopic surgical approach for anterior hyaloid dissection in phakic and pseudophakic patients
KyariManaging cataract surgery in patients with glaucoma
Cavallini et al.Bimanual microphacoemulsification and Acri. Smart intraocular lens implantation combined with vitreoretinal surgery
SinghStep-by-step: intratunnel phacofracture
Laroche et al.Retrobulbar/intraconal tube placement in patients with glaucoma: Ahmed FP-7 and tube extender case series with 1 year follow-up
Aktas et al.GATT international experience: Turkey
MuthukumaranA Comparative Study of Post-Operative Astigmatism Induced by Phacoemulsification and Manual Small Incision Cataract Surgery at MVJMC & RH
JavedPhacoemulsification under Topical Anesthesia Alone Versus Topical Anesthesia with Subconjunctival
Spandau et al.Pars plana vitrectomy for beginners
Perez et al.Traumatic Glaucoma Managed With Ab Interno Trabeculotomy (Trabectome®): A Case Report

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
RJ01Rejection of invention patent application after publication
RJ01Rejection of invention patent application after publication

Application publication date:20160921


[8]ページ先頭

©2009-2025 Movatter.jp